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Isoselenocyanates derived from Boc/Z-amino acids are prepared by the reaction of the corresponding
isonitriles with selenium powder in presence of triethylamine at reﬂux. The utility of these new classes of
isoselenocyanates in the preparation of selenoureidodipeptidomimetics possessing both amino as well as
carboxy termini has been accomplished. The 1H NMR analysis conﬁrmed that the protocol involving the
conversion of isonitriles to isoselenocyanates and their use as coupling agents in assembling selenour-
eido derivatives is free from racemization.
 2010 Elsevier Ltd. All rights reserved.1. Introduction
Peptides and proteins, although, ubiquitous in living cells have
to be modiﬁed chemically to make them employable as drugs
and to prepare artiﬁcial enzymes.1e3 Ureidopeptides, peptidyl
ureas, oligourea/peptide hybrids comprising either a and/or
b-amino acid residues have been prepared and studied.4 Another
new class of mimetics, thioureidopeptides was recently reported
by us.5
Interest in the use of organoselenium compounds (OrgSeCs)
in biochemistry is growing steadily6 due to (i) increase in the
availability of stable OrgSeCs and (ii) the beneﬁcial effects asso-
ciated with them as antioxidants, enzyme inhibitors, cytokine
inducers, immunomodulators, antitumor, antihypertensive, anti-
viral, antibacterial, antifungal, and anti-infective agents.7 Hun-
dreds of OrgSeCs are being used as reagents and intermediates in
organic synthesis. Woollins’ reagent is regularly employed for
various selenation reactions.8 Various strategies and reagents for
the efﬁcient incorporation of selenium functionality into molec-
ular architecture are being developed.9e17 Their utility in the
construction of several classes of heterocycles such as1339; e-mail addresses:
com (V.V. Sureshbabu).
All rights reserved.selenazoles18 and selenohydantoins19 is well documented. Sele-
nosugars including glycosyl isoselenocyanates have been widely
used in carbohydrate chemistry for the preparation of di-
saccharides, C-glycosides, O-glycosides, and glycoconjugates.20
The synthesis of Se-containing compounds is of interest in
peptide science owing to the discovery of a number of seleno-
proteins.21a,22 Selenocysteine (Sec) is being viewed as 21st pro-
teinogenic amino acid because its insertion is genetically
controlled.21,23e26 Glutathione peroxidase (GPx),27 possessing Sec
in the active site, is an antioxidant enzyme, which protects various
organisms from oxidative damage.28 Selenocysteine mediated
chemo-selective ligation is useful in chemical synthesis and semi-
synthesis of large peptides and a range of proteins through native
chemical ligation.29 Despite the growing importance of seleno-
peptides/proteins, the insertion of Se into a peptide sequence is
mainly limited to the above-described studies.30
Isoselenocyanates31 are easy to prepare and store, less toxic and
safe to handle. Along with other applications, their utility especially
in the synthesis of various selenium containing heterocycles is well
documented.32 Their preparation involves reaction of an isonitrile
with Se or direct conversion of formamides into isoselenocyanates
via the isonitrile intermediate.31a,33 Other important reports for
their synthesis include the reaction of phenylimidolyl chloride with
sodium selenide; isocyanates with phosphorous(V) selenide;
treatment of N-aryl-carbimidic dichlorides with sodium selenide;
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nitrile oxides with primary selenoamide and alkylation of seleno-
cyanate ion.34 An apparently convenient protocol would be the
treatment of an amine with carbon diselenide, which is in very
limited use due to the non availability of CSe2.35 There are few other
procedures available, which are yet to gain the merit of general
applicability.36
In the literature, isocyanates37 and isothiocyanates38,39 (2a and
2b) derived from amino/peptide acid esters as well as N-protected
amino acids are known to be employed as key synthons in both de
novo design and for accessing biologically potent molecules4,40e42
(Fig. 1). Their utility as building blocks for the construction of
uriedo/thioureido peptidomimetics has been the focus of several
research publications37,38 (Figs. 1 and 2).PgHN N=C=X
R
X=C=N Y
R
O
1
2
1a. Isocyanates: X = O; n = 0 or 1
      Pg = Fmoc, Boc or Z group.
1b. Isothiocyanates: X = S; n =  1
      Pg = Fmoc, Boc or Z group.
n
2a. Isocyanates: X = O;
      Y = OMe, OEt or OBzl group.
2b. Isothiocyanates: X = S;
      Y = OMe, OEt or OBzl group.
Boc/Z-HN
R
N=C=Se
3 or 4
N-protected isoselenocyanates
Figure 1. Structures of isocyanates, isothiocyanates, and isoselenocyanates derived
from amino acids.
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Figure 2. General structures of peptide and peptidylurea analogs.In continuation of our interest in such mimetics, we now pres-
ent our works on the syntheses of isoselenocyanates 3 and 11 de-
rived from N-Boc/Z-amino acids, hitherto unreported class of
OrgSeCs and demonstrate their utility for the synthesis of sele-
noureido derivatives (Scheme 1).BocHN
R
NC Se powder BocHN
R
BocHN
R H
N
O
burgess 
reagent
BocHN
R
NH2
HCOOH,
DCC
5
7 3
6
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Scheme 1. Preparation of isoselenocyanates 3 derived2. Results and discussion
2.1. Synthesis of isoselenocyanates 3 from N-Boc-amino acids
The isonitriles precursors required for the preparation of re-
spective class of isoselenocyanates were obtained by LiAlH4 re-
duction of the corresponding nitriles of the N-Boc-amino acids
followed by the formylation of the amine group as formamides 6.43
The dehydration of these formamides 6 afforded N-b-Boc-amino
alkyl isonitriles 7 in good yields. These novel classes of isonitriles
could also be useful as precursors for well knownmulti-component
reactions as well.43
As Sonoda et al. have reported that effective conversion of
aliphatic isocyanides to corresponding isoselenocyanates re-
quires an organic base such as TEA,31 we conceived the idea that
the reaction of N-b-Boc-amino alkyl isonitriles 7 with Se powder
would offer new class of isoselenocyanates. In this context,
a mixture of 1 mmol each of Nb-BoceValeJ[CH2NC] 7a and Se
powder in THF in presence of 0.7 mmol of TEA was reﬂuxed. The
reaction was complete in 5e6 h as analyzed by TLC. The corre-
sponding isoselenocyanate 3a was isolated in 90% yield. With
this result, a series of isoselenocyanates (3aej) derived from
corresponding Boc-amino acids were synthesized (Scheme 1),
which could be stored for several weeks at subzero temperature
without any decomposition. The IR spectrum of these iso-
selenocyanates exhibited a sharp peak at 2148 cm1 character-
istic of eNCSe group. While 13C NMR spectrum showed
characteristic signal at around d 125 corresponding to seleno-
carbonyl carbon while 77Se NMR spectrum possesses a signal at
around d 350.2.2. N-Z-Amino alkyl isoselenocyanates 4
Efﬁcacy of the protocol for the synthesis of Boc-amino alkyl
isoselenocyanates 3 prompted us to extend the study to the iso-
nitrile derivatives of Z-amino acids 10, which were obtained
through the dehydration of corresponding formamides 9, prepared
by the formolysis of their isocyanates 8 by following our reported
procedure.43,44 In the ﬁnal step, the selenation of the isonitriles 10
was undertaken to afford Nb-ZeXaaeJ[CH2NCSe]s 4 in satisfactory
yield (Scheme 2).
Further, for the insertion of isoselenocyanate moiety in the side
chain of an amino acid, the g-carboxyl group of Glu was converted
to the corresponding isonitrile using oxazolidinone as bidentate
protection for a-amino and carboxy groups.45 Na-ZeGlueOH de-
rived oxazolidinone was prepared employing microwave assisted
transformation of g-carboxyl group of Na-ZeGlueOH to formamide
via formylation of corresponding isocyanate. It was dehydrated and
converted to corresponding isoselenocyanate 11 as described
before (Fig. 3).NCSe
H
Yield (%)Sl. 
No.
Amino 
acid 6 7 3
1 Val 89 89 90
2 Leu 88 92 95
3 Ile 89 90 92
4 Phe 91 95 96
5 Phg 92 93 89
6 Pro 80 88 85
7 Met 88 93 88
8 Cys(Bzl) 87 91 80
9 Ser(Bzl) 82 90 86
10 Aib 82 90 92
from Boc-amino acids and the respective yields.
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Yield (%)Sl. 
No.
Amino 
acid 9 10 4
1 Ala 82 82 91
2 Val 87 92 84
3 Leu 85 85 83
4 Ile 82 89 88
5 Phe 90 93 90
6 Pro 75 80 77
7 Met 86 83 88
8 Cys(Bzl) 79 79 75
9 Ser(Bzl) 76 81 76
10 Lys(Boc) 75 74 79
Scheme 2. Preparation of isoselenocyanates 4 derived from Z-amino acids.
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Figure 3. Structure of isoselenocyanate derived from ZeGlue5-oxazolidinone.
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selenoureidopeptides 13aef
In general, selenoureas are prepared by the reaction of an iso-
selenocyanate with an amino component.9a,46 In order to demon-
strate the synthetic utility of the isoselenocyanates 3 and 4, ﬁve
unsymmetrical selenoureas were prepared. In the ﬁrst set of ex-
periments 3a, 3b, 3d, 4d,11ewere made to react with ﬁve different
aromatic amines (Scheme 3, Table 1). All the selenoureas 12aee
were obtained in good yield after column chromatographic puriﬁ-
cation using ethyl acetate/hexane (9:1). However, the reaction of 3
with aromatic amines possessing electron-withdrawing groups
attached to the aromatic nucleus failed to form corresponding
selenoureas. Among the various spectral data recorded for these
selenoureas, the chemical shifts of compounds 12 and 13 in 77Se
NMR were observed approximately at d 280.
Our long-term interest in the area of peptidomimetics has
resulted in the design and insertion of ureido/thioureido moietyPgHN
R1
NPgHN
R1 H
N
H
N R3
Se
R3-NH2
CH2Cl2, rt,
0.5 h
12a-e
3: Pg= Boc
4: Pg= Z
Scheme 3. Synthesis of selenoureas
Table 1
List of selenoureas 12 and selenoureidodipeptides 13 synthesized
Entry Pg R1 R3 Yield (%) Entry
12a Boc CH(CH3)2
Cl 94 13a
12b Boc CH2C6H5 98 13b
12c Boc CH2CH(CH3)2 98 13c
12d Z CH2C6H5 98 13d
12e Z CH(CH3)(C2H5) Br
98 13e
13f[eNHeCXeNHe, X¼O or S] in place of peptide bond. In this di-
rection, we have now prepared six selenoureidodipeptides 13aef. It
has been found that the reaction of 3 or 4with an amino acid ester
was clean and complete within 30 min at room temperature
(Scheme 3). After regular workup, the selenoureido products 13aef
were obtained in about 90% yield (Table 1).2.4. Tests for racemization
Racemization while formation of the isoselenocyanates and
during the coupling with amines as well as amino acid esters
was expected to be unlikely considering the mild conditions
chosen for the functional group transformations. However, as the
penultimate part of this study, we undertook the synthesis of
three sets of epimeric selenoureas. In the ﬁrst two sets, BoceL-
PheeJ[CH2NCSe] 3d, and ZeL-PheeJ[CH2NCSe] 4e were cou-
pled with (R)-, (S)- and a racemic mixture of 1-phenylethylamine
in parallel experiments and six selenoureas 14aec and 15aec
were isolated (Fig. 4). In each set, 1H NMR of the particular
epimers contained a single distinct methyl group doublet. Ob-
served d values for the eCH3 group of the compounds are as
follows: 14a: 1.34, 1.32 and 14b: 1.26, 1.24; 15a: 1.50, 1.48 and
15b: 1.56, 1.54. Further, the compounds 14c and 15c, prepared by
coupling the corresponding isoselenocyanates with racemic 1-
phenylethylamine showed two distinct doublets in each caseCSe PgHN
R1 H
N
H
N
Se R2
OY
O
CH2Cl2, rt,
0.5 h
13a-f
H2N COOY
R2
12 and selenoureidopeptides 13.
Pg R1 R2 Y Yield (%)
Boc CH2C6H5 CH(CH3)2 Me 95
Boc CH(CH3)2 CH2CH(CH3)2 Me 92
Boc CH2CH(CH3)2 H Me 98
Z (CH2)2SCH3 CH3 Me 95
Z CH(CH3)2 CH(CH3)(C2H5) Bzl 90
Z CH2CH(CH3)2 CH(CH3)2 Me 92
BocHN
H
N
H
N ∗
Se
14a: R at *; 14b S at *; 14c: R and S at *
ZHN
H
N
H
N ∗
Se
15a: R at *; 15b: S at *; 15c: R and S at *
Figure 4. Epimeric diselenoureidopeptides synthesized for racemization studies.
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absence of racemization.2.5. Crystal structures of BocePheeJ[CH2NC] 7d, BoceValeJ
[CH2NCSe] 3a, BocePheeJ[CH2NCSe] 3d, and ZeLeueJ
[CH2NCSe] 4c
It is important tomention that notmanyN-protected amino acid
derived synthons have been crystallized although a small portion of
conformationally restricted amino acid derivatives are studied
throughX-ray crystallography. Recently,wehad reported the crystal
structure of novelN-Boc-amino alkyl isothiocyanates obtained from
Gly and Phe.21 Guichard’s group reported the crystal structures of
succinimidyl carbamates of BoceProeOH and BoceProeValeOH,
which were derived from their corresponding isocyanates.41c In the
present work, three isoselenocyanates namely, BoceValeJ
[CH2NCSe] 3a, BocePheeJ[CH2NCSe] 3d, ZeLeueJ[CH2NCSe] 4c,
and an isonitrile BocePheeJ[CH2NC] 7d have been isolated as
crystals and their structures have been determined. To the best of
our knowledge, this is the ﬁrst report on the crystal structure anal-
ysis of amino acid derivatives containing an isocyano group or iso-
selenocyanato group.
BocePheeJ[CH2NC] 7d crystallizes in the orthorhombic
crystal system in the non-centrosymmetric space group P212121
with Z0¼1. Compound 7d (Fig. 5) shows the asymmetric unit and
the atom-numbering scheme (see Supplementary data). In the
asymmetric unit, the plane of the phenyl ring is tilted from the
rest of the molecule at a dihedral angle C5eC6eC11eC15 of
74.91. As expected, the CeNþ^C bond is nearly linear, with
a C10eN2eC14 angle of 178.33. The molecular assembly is
chieﬂy stabilized by an extensive network of NeH/O strongFigure 5. Crystal structure of BocePheeJ[CH2NC] 7d showing the atom-numbering
scheme. Displacement ellipsoids are drawn at the 50% probability level and H atoms
have been omitted for the sake of clarity.hydrogen bonds in the ac plane, wherein the nitrogen atom of
the amino group acts as a donor to the hydrogen bond acceptor,
oxygen of the carbonyl moiety. The NeH/O interactions are
further supplemented with CeH/p weak interactions along the
a axis.
BoceValeJ[CH2NCSe] 3a and BocePheeJ[CH2NCSe] 3d crys-
tallize in the orthorhombic crystal system in the non-centrosym-
metric space group P212121 with Z0¼1 and in the asymmetric unit,
the N]C]Se bond is nearly linear with an angle of 177.79 and
178.59, respectively. The ZeLeueJ[CH2NCSe] 4c crystallize in the
monoclinic crystal system in the non-centrosymmetric space group
P21, with Z0¼1 with N]C]Se bond almost linear at an angle of
178.68 (Fig. 6). The selected bond lengths, crystal data and struc-
ture reﬁnement parameters, selected torsion angles, and hydrogen
bonding geometry of the above crystals have been furnished in
Supplementary data.
3. Summary
In summary, we have delineated a simple protocol for the
preparation of new classes of isoselenocyanates derived from Boc
as well as Z-protected amino acids. These two classes of chiral
OrgSeCs were isolated in good yields and fully characterized. The
isoselenocyanates 3 and 4 are storable at 0 C. Three samples of
N-Boc/Z-amino acid derived isoselenocyanates were obtained as
single crystals and their structure was conﬁrmed through X-ray
crystallography. Straightforward reaction of isoselenocyanates 3
and 4 with amino components has yielded selenour-
eidopeptidomimetics and unsymmetrical selenoureas.
4. Experimental
4.1. General
All amino acids were used as obtained from SigmaeAldrich
Company, USA. Unless or otherwise mentioned, all amino acids
used were of L-conﬁguration. All the solvents were dried and pu-
riﬁed using recommended procedures in the literature whenever
necessary. High resolution mass spectra were recorded on
a Micromass Q-TOF micromass spectrometer using electron spray
ionization mode, elemental analyses were carried out using Carlo
Erba 1106 CHN analyzer, 1H NMR and 13C NMR spectra were
recorded on a Bruker AMX 300 MHz and 100 MHz spectrometer,
respectively, at the Indian Institute of Science, Bangalore. IR spectra
were recorded on a Schimadzu model FT-IR spectrometer at Ban-
galore University, Bangalore. Melting points were determined in an
open capillary and are uncorrected. TLC experiments were done
using MERCK TLC aluminum sheets (silica gel 60 F254) and
chromatograms were visualized by exposing in iodine chamber,
UV-lamp or spraying with KMnO4, and heating. Column chroma-
tography was performed on silica gel (100e200 mesh) using ethyl
acetate and hexane mixtures as eluent.
4.2. Typical procedure for formamides derived from Boc-
amino acids 6
To the CH2Cl2 solution ofN-Boc-b-amino alkyl amine (10.0 mmol
5) at 0 C were added ethyl-3-(3-dimethylaminopropyl)carbodi-
imide (EDC) (2.1 g, 11.0 mmol) and 98% of formic acid (0.42 mL,
11.0 mmol). After stirring the mixture for 3 h, the reaction mixture
wasﬁltered and theﬁltratewas evaporated under reduced pressure.
The crudemixturewas dilutedwithCH2Cl2 (20 mL) andwaswashed
with 5% Na2CO3, water, and brine, dried over anhydrous sodium
sulfate, and the solvent was removed in vacuo. The crude was sub-
jected to column puriﬁcation (Silicagel 100e200 mesh, 20% EtOAc/
hexane).
Figure 6. The molecular structures of A. BoceValeJ[CH2NCSe] 3a; B. BocePheeJ[CH2NCSe] 3d and C. ZeLeueJ[CH2NCSe] 4c showing the atom-labeling scheme. Displacement
ellipsoids are drawn at the 50% probability level and H atoms have been omitted for the sake of clarity.
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(BoceValeJ[CH2NHCHO]) (6a). Compound6awaspreparedby the
above method and puriﬁed by column chromatography using 5:1
hexanes/EtOAc to afford 6a (89%) as a white solid: mp 74e76 C; Rf
value 0.24 (n-hexane/EtOAc 1:1); [a]D25 4.1 (c 1.0, CHCl3); IR (KBr) n
1654,1710; 1HNMR (300MHz, DMSO-d6) d 0.95 (6H, d, J¼6.7 Hz,eCH
(CH3)2), 1.42 (9H, s, eC(CH3)3), 1.65e1.88 (1H, m, eCH(CH3)2),
3.25e3.37 (2H,m,eCH2eNHCHO), 4.08 (1H,m,eCHeCH2e), 6.62 (1H,
m, NH), 8.05 (1H, m,eNHCHO); 13C NMR (100MHz, DMSO-d6) d 18.5,
19.3, 28.3, 29.1, 44.1, 54.2, 79.7, 155.4, 162.3; MS (ESI-HR)m/z calcd for
C11H22N2NaO3 253.1528 (MþNaþ), found 253.1525 (MþNaþ).4.3. Typical procedure for formamides derived from Z-amino
acids 9
To aTHF solutionofN-Z-b-amino acid (10.0 mmol) at20 Cwere
added N-methylmorpholine (1.21 mL, 11.0 mmol) and ethyl chloro-
formate (1.05 mL,11.0 mmol). After stirring themixture for 10 min, aq
sodium azide (975 mg, 15 mmol) was added and the stirring was
continued until completion of the reaction (TLC analysis). The re-
actionmixture was concentrated under vacuum and the residuewas
dissolved in 30.0 mL of CH2Cl2. The organic layer was washed with
20mL each of 5% Na2CO3,10% citric acid, water, and brine, dried over
anhydrous sodium sulfate, and evaporated under reduced pressure.
The resulting residuewas dissolved in 15.0 mL of toluene and heated
at 65 C for 30 min under argon. Upon complete formation of the
isocyanate (strong IR peak at 2220 cm1 and absence of azide peak at
2100 cm1), toluenewas removed invacuo. The isocyanates obtained
were dissolved in 15 mL of dry CH2Cl2 and the solutionwas stirred at
15 C with the addition of 98% formic acid (0.77 mL, 20mmol) and
DMAP (36 mg, 0.3 mmol), till the end of the reaction. The reaction
mixturewas dilutedwith CH2Cl2 andwashedwith 20mL each of 10%
citric acid, 5% Na2CO3, water, and brine solution and dried over an-
hydrous Na2SO4 and the solvent was evaporated under vaccum. Thecrudewas subjected to columnpuriﬁcation (Silicagel 100e200mesh,
20% EtOAc/n-hexane).
4.3.1. (S)-Benzyl 1-formamido-4-(methylthio)butan-2-ylcarba-
mate (ZeMeteJ[CH2NHCHO]) (9g). Compound 9awas prepared
by the above method and puriﬁed by column chromatography
using 5:1 hexanes/EtOAc to afford 9a (86%) as a white solid: mp
124e126 C; Rf value 0.22 (n-hexane/EtOAc 1:1); [a]D25 20.3 (c 1.0,
CHCl3); IR (KBr) n 1666,1703; 1H NMR (300 MHz, CDCl3) d 1.61e1.72
(2H, m, CH3eSeCH2CH2e), 2.04 (3H, s, CH3eSe), 2.47e2.58 (2H, m,
CH3eSeCH2e), 3.27e3.45 (2H, m, eCH2eNHCHO), 3.82 (1H, m,
eCHeCH2e), 5.02 (2H, s, AreCH2), 6.30 (1H, br, NH), 7.12e7.32 (5H,
m, ArH), 8.20 (1H, s, eNHCHO); 13C NMR (100 MHz, CDCl3) d 16.0,
29.6, 31.8, 43.4, 54.1, 66.2, 127.3, 128.0, 128.7, 136.1, 156.4, 162.6; MS
(ESI-HR) m/z calcd for C14H20N2NaO3S 319.1092 (MþNaþ), found
319.1096 (MþNaþ).4.4. General procedure for the preparation N-Boc/Z-amino
acid derived isonitriles 7 and 10
Burgess reagent (3.57 g, 15.0 mmol) was added to a solution of
formamide 6aej or 9aej (10.0 mmol) in dry CH2Cl2 (20 mL) and the
resulting solutionwas reﬂuxed till completion of the reaction (TLC).
It was diluted with CH2Cl2 (10 mL) and washed with water
(210 mL), brine (10 mL), dried over anhydrous sodium sulfate and
was concentrated in vacuo to obtain the crude product that was
puriﬁed by column chromatography (100e200 mesh silica gel)
using 10% ethyl acetate in hexane. Alternatively, the reaction mix-
ture was concentrated in vacuo and the crude compound was pu-
riﬁed by column chromatography to obtain pure isonitrile.
4.4.1. (S)-tert-Butyl 1-isocyano-4-methylpentan-2-ylcarbamate
(BoceLeueJ[CH2NC]) (7b). Compound 7b was prepared by the
above method and puriﬁed by column chromatography using 9:1
G. Chennakrishnareddy et al. / Tetrahedron 66 (2010) 6718e6724 6723hexanes/EtOAc to afford 7b (92%) as a white solid: mp 55e57 C; Rf
value 0.47 (n-hexane/EtOAc 4:1); [a]D2522.4 (c 1.0, CHCl3); IR (KBr) n
1687, 2146; 1H NMR (300 MHz, CDCl3) d 1.01 (6H, d, J¼5.6 Hz, eCH
(CH3)2), 1.48 (9H, s, eC(CH3)3), 1.72e1.80 (2H, m, eCH2eCH(CH3)2),
1.88 (1H, m,eCH(CH3)2), 3.43e3.64 (2H, m,eCHeCH2e), 4.11 (1H, m,
eCHeCH2e), 5.28 (1H, br,NH); 13CNMR(100MHz,CDCl3) d22.0, 23.9,
24.1, 28.2, 40.7, 47.4, 49.4, 80.1, 154.3,156.2; MS (ESI-HR)m/z calcd for
C12H22N2NaO2 m/z 249.1579 (MþNaþ), found 249.1575 (MþNaþ).
4.4.2. (S)-Benzyl 1-isocyano-3-phenylpropan-2-ylcarbamate (ZePheeJ
[CH2NC]) (10e). Compound 10ewas obtained as a white solid (93%):
mp 130e132 C; Rf value 0.45 (n-hexane/EtOAc 4:1); [a]D25 16.0 (c
1.0, CHCl3); IR (KBr) n 1697, 2148; 1H NMR (300 MHz, CDCl3)
d 2.34e2.48 (2H, m, eCHeCH2eAr), 3.36e3.51 (2H, m, eCH2eNC),
3.92 (1H, m, eCHeCH2eNC), 5.12 (2H, s, AreCH2), 5.68 (1H, br, NH),
7.13e7.46 (10H, m, ArH); 13C NMR (100 MHz, CDCl3) d 39.8, 42.4,
52.9, 67.3, 127.5, 128.4, 128.4, 128.9, 129.2, 130.1, 136.8, 137.9, 157.7,
163.0; MS (ESI-HR)m/z calcd for C18H18N2NaO2 317.1266 (MþNaþ),
found 317.1256 (MþNaþ).
4.5. General procedure for the synthesis of isoselenocyanates
3 and 4
To a solution of N-Boc/Z-amino acid derived isonitriles 7 or 10
(1 mmol) in dry THF (12 mL), TEA (0.97 mL, 0.7 mmol) and sele-
nium powder (2.37 g, 3 mmol) were added. It was reﬂuxed for
a minimum of 5 h. After the completion of reaction (TLC), it was
allowed to cool to room temperature and was passed through a pad
of Celite. The ﬁltrate was diluted with ethyl acetate (15 mL) and
washed with dilute citric acid (10 mL2), water (10 mL2), and
brine (10 mL). The organic phase was dried over anhydrous sodium
sulfate and concentrated. The crude was puriﬁed by column chro-
matography (silica gel 100e200 mesh, 10% ethyl acetate in hexane)
to afford the product as crystalline solid.
4.5.1. (S)-tert-Butyl 1-isoselenocyanato-4-methylpentan-2-ylcarba-
mate (BoceLeueJ[CH2NCSe]) (3b). Compound 3bwas prepared by
the above method and puriﬁed by column chromatography using
9:1 hexanes/EtOAc to afford 3b (95%) as a white solid: mp
89e91 C; Rf value 0.51 (n-hexane/EtOAc 4:1); [a]D25 122.4 (c 1.0,
CHCl3); IR (KBr) n 1697, 2148; 1H NMR (300 MHz, CDCl3) d 0.95 (6H,
d, J¼5.2 Hz, eCH(CH3)2), 1.45 (9H, s, eC(CH3)3), 1.47e1.70 (3H, m,
eCH2eCH(CH3)2), 3.55e3.77 (2H, m, eCH2eNCSe), 4.61 (1H, m,
eCHeCH2eNCSe), 5.48 (1H, br, NH); 13C NMR (100 MHz, CDCl3)
d 22.1, 24.8, 28.4, 40.8, 48.3, 49.8, 58.9, 80.2, 124.5, 155.1; 77Se NMR
(CDCl3) d 357.6; MS (ESI-HR) m/z calcd for C12H23N2NaO2Se
329.0744 (MþNaþ), found 329.0739 (MþNaþ).
4.5.2. (S)-Benzyl 1-isoselenocyanatopropan-2-ylcarbamate (ZeAlaeJ
[CH2NCSe]) (4a). Compound 4awas prepared by the above method
andpuriﬁedbycolumnchromatographyusing5:1hexanes/EtOAc to
afford 4a (91%) as gum. Rf value 0.49 (n-hexane/EtOAc 4:1); [a]D25
11.6 (c1.0, CHCl3); IR (neat) n1714, 2148; 1HNMR (300 MHz, CDCl3)
d 1.25 (3H, d, J¼4.9 Hz, eCHeCH3), 3.35e3.55 (2H, m, CH2eNCSe),
4.20 (1H,m,eCHeCH2eNCSe), 5.10 (2H, s, AreCH2e), 7.23e7.48 (5H,
m, ArH); 13C NMR (100 MHz, CDCl3) d 20.6, 53.4, 62.2, 69.0, 128.1,
128.5,128.7,128.9,134.6,155.1; 77Se NMR (CDCl3) d356.6;MS (ESI)
m/z calcd for C12H14N2O2Se 321.0 (MþNaþ), found 321.0 (MþNaþ).
4.6. General procedure for the synthesis of Nb-Boc/Z-
protected unsymmetrical selenoureas 12 and
selenoureidopeptides 13
To a solution of Nb-Boc/Z-amino alkyl isoselenocyanate 3 or 4
(1 mmol) in CH2Cl2 (15 mL), a solution of amino acid ester
(1.3 mmol, obtained by neutralizing the corresponding salt withequimolar quantity of NMM in CH2Cl2) or an organic amine was
added and the reaction mixture was stirred at room temperature
for about 30 min. After the completion of reaction as monitored by
TLC, it was diluted with CH2Cl2 (10 mL), 10% citric acid solution
(10 mL) was added and the layers were separated. The organic layer
was subsequently washed with water, brine and ﬁnally dried over
anhydrous sodium sulfate. It was concentrated in vacuo to afford
the title compounds as pure solids.
4.6.1. (S)-tert-Butyl 1-(3-(3-chlorophenyl)selenoureido)-3-methylbutan-
2-ylcarbamate (BoceValeJ[CH2NHCSeNH]em-Cl-C6H4) (12a). Com-
pound 12a was prepared by the above method and puriﬁed by
column chromatography using 7:3 hexanes/EtOAc to afford 12a
(88%) as a white solid: mp 139e141 C; Rf value 0.40 (n-hexane/
EtOAc 1:1); IR (neat) n 1546, 1693; 1H NMR (300 MHz, CDCl3) d 0.95
(6H, d, J¼5.6 Hz, eCH(CH3)2), 1.32 (9H, s, eC(CH3)3), 1.82 (1H, m,
eCH(CH3)2), 3.59 (1H, m, eCHeCH2eNHe), 3.65e3.80 (2H, m,
eCHeCH2eNHe), 4.72 (1H, br, NH), 7.19e7.55 (4H, m, ArH), 8.67
(1H, br, NH); 13C NMR (100 MHz, CDCl3) d 18.1, 28.1, 30.7, 52.7, 55.4,
79.9, 123.2, 125.2, 127.2, 130.8, 135.4, 137.2, 157.0, 179.1; 77Se NMR
(CDCl3) d 261.1; MS (ESI) m/z calcd for C17H26ClN3O2Se 442.1
(MþNaþ), found 442.2 (MþNaþ). Anal. Calcd for C17H26ClN3O2Se: C,
48.75; H, 6.26; N, 10.03. Found: C, 48.77; H, 6.29; N, 10.04.
4.6.2. (S)-Methyl 2-(3-((S)-2-(benzyloxycarbonyl)-4-(methylthio)bu-
tyl)selenoureido) propanoate (ZeMeteJ[CH2NHCSeNH]eAlaeOMe)
(13d). Compound 13b was prepared by the above method and
puriﬁed by column chromatography using 5:1 hexanes/EtOAc to
afford 13b (95%) as gum; Rf value 0.35 (n-hexane/EtOAc 1:1); IR
(neat) n 1512, 1693, 1740; 1H NMR (300 MHz, CDCl3) d 1.10e1.45
(3H, d, J¼5.7 Hz, eCHeCH3), 1.81e2.00 (2H, m, eCH2eCH2eSe),
2.05 (3H, s, eSeCH3), 2.55 (2H, m, eCH2eCH2eSe), 3.48e3.56 (2H,
m, eCHeCH2eNHe), 3.68 (3H, s, eCOOCH3), 3.82 (1H, m,
eCHeCH2eNe), 3.89 (1H, m, eNHeCHe), 5.31 (2H, s, AreCH2e),
7.14e7.48 (5H, m, ArH); 13C NMR (100 MHz, CDCl3,) d 17.5, 17.9, 29.9,
31.9, 48.2, 49.5, 53.4, 56.2, 67.2,127.1,127.3,127.6,128.3,128.6,137.2,
155.4,172.6,183.2; 77Se NMR (CDCl3) d 262.2; MS (ESI-HR)m/z calcd
for C18H27N3O4SSe 484.0785 (MþNaþ), found 484.0781 (MþNaþ).
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